{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T02:02:24Z","timestamp":1784340144149,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R37CA240846-01A1"],"award-info":[{"award-number":["R37CA240846-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA77598"],"award-info":[{"award-number":["P30 CA77598"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Neoplasia"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.bneo.2024.100057","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:08:52Z","timestamp":1731629332000},"page":"100057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cerebrospinal fluid attenuates the efficacy of methotrexate against acute lymphoblastic leukemia cells"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-6411-4728","authenticated-orcid":false,"given":"Jongseok","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Ostergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3159-1881","authenticated-orcid":false,"given":"Peter M.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4 suppl 2","key":"10.1016\/j.bneo.2024.100057_bib1","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1053\/j.seminoncol.2009.05.002","article-title":"Central nervous system disease in hematologic malignancies: historical perspective and practical applications","volume":"36","author":"Pui","year":"2009","journal-title":"Semin Oncol"},{"issue":"12","key":"10.1016\/j.bneo.2024.100057_bib2","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1038\/s41375-022-01714-x","article-title":"Central nervous system involvement in childhood acute lymphoblastic leukemia: challenges and solutions","volume":"36","author":"Thastrup","year":"2022","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.bneo.2024.100057_bib3","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3390\/biom12060813","article-title":"Flow cytometric detection of malignant blasts in cerebrospinal fluid: a biomarker of central nervous system involvement in childhood acute lymphoblastic leukemia","volume":"12","author":"Thastrup","year":"2022","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.bneo.2024.100057_bib4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/archinte.1958.00260140111016","article-title":"Intrathecal amethopterin in neurological manifestations of leukemia","volume":"101","author":"Whiteside","year":"1958","journal-title":"AMA Arch Intern Med"},{"issue":"1","key":"10.1016\/j.bneo.2024.100057_bib5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00043426-198921000-00017","article-title":"Central nervous system pharmacology of antileukemic drugs","volume":"11","author":"Balis","year":"1989","journal-title":"Am J Pediatr Hematol Oncol"},{"issue":"6","key":"10.1016\/j.bneo.2024.100057_bib6","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1158\/1078-0432.CCR-06-2854","article-title":"The blood-brain barrier and cancer: transporters, treatment, and Trojan horses","volume":"13","author":"Deeken","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.bneo.2024.100057_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11899-021-00640-6","article-title":"Management of CNS disease in pediatric acute lymphoblastic leukemia","volume":"17","author":"McNeer","year":"2022","journal-title":"Curr Hematol Malig Rep"},{"issue":"23","key":"10.1016\/j.bneo.2024.100057_bib8","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1182\/blood-2016-06-721712","article-title":"Hypoxic adaptation of leukemic cells infiltrating the CNS affords a therapeutic strategy targeting VEGFA","volume":"129","author":"Kato","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bneo.2024.100057_bib9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1158\/2643-3230.BCD-20-0216","article-title":"Multiomic profiling of central nervous system leukemia identifies mRNA translation as a therapeutic target","volume":"3","author":"Vanner","year":"2022","journal-title":"Blood Cancer Discov"},{"issue":"4","key":"10.1016\/j.bneo.2024.100057_bib10","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.3324\/haematol.2016.152926","article-title":"The central nervous system microenvironment influences the leukemia transcriptome and enhances leukemia chemo-resistance","volume":"102","author":"Gaynes","year":"2017","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.bneo.2024.100057_bib11","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/s43018-020-00115-2","article-title":"Metabolic adaptation of acute lymphoblastic leukemia to the central nervous system microenvironment is dependent on Stearoyl CoA desaturase","volume":"1","author":"Savino","year":"2020","journal-title":"Nat Cancer"},{"key":"10.1016\/j.bneo.2024.100057_bib12","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1038\/s41375-022-01722-x","article-title":"Central nervous system involvement in childhood acute lymphoblastic leukemia is linked to upregulation of cholesterol biosynthetic pathways","volume":"36","author":"Cousins","year":"2022","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.bneo.2024.100057_bib13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1182\/blood-2017-03-769315","article-title":"Central nervous system involvement in acute lymphoblastic leukemia is mediated by vascular endothelial growth factor","volume":"130","author":"M\u00fcnch","year":"2017","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bneo.2024.100057_bib14","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/bjh.13887","article-title":"New cellular markers at diagnosis are associated with isolated central nervous system relapse in paediatric B-cell precursor acute lymphoblastic leukaemia","volume":"172","author":"van der Velden","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bneo.2024.100057_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.expneurol.2015.07.027","article-title":"A\u00a0balanced view of the cerebrospinal fluid composition and functions: focus on adult humans","volume":"273","author":"Spector","year":"2015","journal-title":"Exp Neurol"},{"issue":"3","key":"10.1016\/j.bneo.2024.100057_bib16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/bjh.16270","article-title":"The meninges enhance leukaemia survival in cerebral spinal fluid","volume":"189","author":"Basile","year":"2020","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.bneo.2024.100057_bib17","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s00216-012-6581-7","article-title":"Measuring methotrexate polyglutamates in red blood cells: a new LC-MS\/MS-based method","volume":"405","author":"den Boer","year":"2013","journal-title":"Anal Bioanal Chem"},{"issue":"3","key":"10.1016\/j.bneo.2024.100057_bib18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.hoc.2012.02.002","article-title":"The antifolates","volume":"26","author":"Visentin","year":"2012","journal-title":"Hematol Oncol Clin North Am"},{"issue":"4","key":"10.1016\/j.bneo.2024.100057_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drup.2012.07.002","article-title":"Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance","volume":"15","author":"Gonen","year":"2012","journal-title":"Drug Resist Updat"},{"issue":"1","key":"10.1016\/j.bneo.2024.100057_bib20","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/1097-0142(197507)36:1<232::AID-CNCR2820360126>3.0.CO;2-F","article-title":"Proliferative kinetics of central nervous system (CNS) leukemia","volume":"36","author":"Kuo","year":"1975","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.bneo.2024.100057_bib21","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/1097-0142(197809)42:3<1255::AID-CNCR2820420334>3.0.CO;2-M","article-title":"Proliferative kinetics of the leukemic cells in meningeal leukemia","volume":"42","author":"Tsuchiya","year":"1978","journal-title":"Cancer"},{"issue":"14","key":"10.1016\/j.bneo.2024.100057_bib22","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM199610033351408","article-title":"Intrinsic and acquired resistance to methotrexate in acute leukemia","volume":"335","author":"Gorlick","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.bneo.2024.100057_bib23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.18388\/abp.1995_4899","article-title":"Molecular mechanisms of resistance to antifolates, a review","volume":"42","author":"Banerjee","year":"1995","journal-title":"Acta Biochim Pol"},{"issue":"2","key":"10.1016\/j.bneo.2024.100057_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1084\/jem.20181965","article-title":"Toward a better understanding of folate metabolism in health and disease","volume":"216","author":"Zheng","year":"2019","journal-title":"J\u00a0Exp Med"},{"issue":"20","key":"10.1016\/j.bneo.2024.100057_bib25","doi-asserted-by":"crossref","first-page":"7154","DOI":"10.1073\/pnas.84.20.7154","article-title":"Identification of methotrexate transport deficiency in mammalian cells using fluoresceinated methotrexate and flow cytometry","volume":"84","author":"Assaraf","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.bneo.2024.100057_bib26","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3109\/00498254.2013.845705","article-title":"Folate, folic acid and 5-methyltetrahydrofolate are not the same thing","volume":"44","author":"Scaglione","year":"2014","journal-title":"Xenobiotica"},{"issue":"1-2","key":"10.1016\/j.bneo.2024.100057_bib27","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cca.2006.03.004","article-title":"Determination of 5-methyltetrahydrofolate in cerebrospinal fluid of paediatric patients: reference values for a paediatric population","volume":"371","author":"Ormazabal","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.bneo.2024.100057_bib28","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/978-1-0716-2565-1_28","article-title":"Quantitation of 5-methyltetrahydrofolate in cerebrospinal fluid using liquid chromatography-electrospray-tandem mass spectrometry","volume":"2546","author":"Arning","year":"2022","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/j.bneo.2024.100057_bib29","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1038\/s41467-020-16747-y","article-title":"A multi-omics analysis reveals the unfolded protein response regulon and stress-induced resistance to folate-based antimetabolites","volume":"11","author":"Reich","year":"2020","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.bneo.2024.100057_bib30","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.15252\/embr.201642195","article-title":"The integrated stress response","volume":"17","author":"Pakos-Zebrucka","year":"2016","journal-title":"EMBO Rep"},{"key":"10.1016\/j.bneo.2024.100057_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1206561","article-title":"The integrated stress response in cancer progression: a force for plasticity and resistance","volume":"13","author":"Lines","year":"2023","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.bneo.2024.100057_bib32","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1083\/jcb.201702058","article-title":"Multi-omics analysis identifies ATF4 as a key regulator of the mitochondrial stress response in mammals","volume":"216","author":"Quir\u00f3s","year":"2017","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.bneo.2024.100057_bib33","article-title":"The integrated stress response as a key pathway downstream of mitochondrial dysfunction","volume":"27","author":"Bilen","year":"2022","journal-title":"Curr Opin Physiol"},{"issue":"516","key":"10.1016\/j.bneo.2024.100057_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax2863","article-title":"Inhibition of mitochondrial translation overcomes venetoclax resistance in AML through activation of the integrated stress response","volume":"11","author":"Sharon","year":"2019","journal-title":"Sci Transl Med"},{"issue":"4","key":"10.1016\/j.bneo.2024.100057_bib35","first-page":"703","article-title":"Clinical pharmacology of intrathecal methotrexate. I. Pharmacokinetics in nontoxic patients after lumbar injection","volume":"61","author":"Bleyer","year":"1977","journal-title":"Cancer Treat Rep"},{"issue":"4","key":"10.1016\/j.bneo.2024.100057_bib36","first-page":"709","article-title":"Role of drug concentration, duration of exposure, and endogenous metabolites in determining methotrexate cytotoxicity","volume":"61","author":"Pinedo","year":"1977","journal-title":"Cancer Treat Rep"},{"issue":"12","key":"10.1016\/j.bneo.2024.100057_bib37","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1080\/10428190600942769","article-title":"Very high-dose methotrexate (33.6 g\/m(2)) as central nervous system preventive therapy for childhood acute lymphoblastic leukemia: results of National Cancer Institute\/Children\u2019s Cancer Group trials CCG-191P, CCG-134P and CCG-144P","volume":"47","author":"Nathan","year":"2006","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.bneo.2024.100057_bib38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00685832","article-title":"A\u00a0slow-release methotrexate formulation for intrathecal chemotherapy","volume":"32","author":"Chatelut","year":"1993","journal-title":"Cancer Chemother Pharmacol"},{"issue":"8","key":"10.1016\/j.bneo.2024.100057_bib39","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/MPH.0000000000000642","article-title":"Efficacy and toxicity of intrathecal liposomal cytarabine in first-line therapy of childhood acute lymphoblastic leukemia","volume":"38","author":"Levinsen","year":"2016","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.bneo.2024.100057_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2021.106059","article-title":"The two faces of the integrated stress response in cancer progression and therapeutic strategies","volume":"139","author":"Licari","year":"2021","journal-title":"Int J Biochem Cell Biol"},{"issue":"6","key":"10.1016\/j.bneo.2024.100057_bib41","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1073\/pnas.1815767116","article-title":"Small molecule ISRIB suppresses the integrated stress response within a defined window of activation","volume":"116","author":"Rabouw","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.bneo.2024.100057_bib42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/pbc.24228","article-title":"Systematic review and meta-analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia","volume":"60","author":"Richards","year":"2013","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"10.1016\/j.bneo.2024.100057_bib43","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1097\/MPH.0b013e3181ec0c25","article-title":"Intrathecal liposomal cytarabine in relapsed or refractory infant and pediatric leukemias: the Children\u2019s Hospital of Philadelphia experience and review of the literature","volume":"32","author":"Seif","year":"2010","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"23","key":"10.1016\/j.bneo.2024.100057_bib44","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1200\/JCO.19.02892","article-title":"Impact of intrathecal triple therapy versus intrathecal methotrexate on disease-free survival for high-risk B-lymphoblastic leukemia: Children\u2019s Oncology Group study AALL1131","volume":"38","author":"Salzer","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.bneo.2024.100057_bib45","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1182\/blood-2005-12-011809","volume":"108","author":"Matloub","year":"2006","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.bneo.2024.100057_bib46","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1016\/j.neuron.2022.08.009","article-title":"Choroid plexus-CSF-targeted antioxidant therapy protects the brain from toxicity of cancer chemotherapy","volume":"110","author":"Jang","year":"2022","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.bneo.2024.100057_bib47","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s10495-005-2947-z","article-title":"Ornithine decarboxylase prevents methotrexate-induced apoptosis by reducing intracellular reactive oxygen species production","volume":"10","author":"Huang","year":"2005","journal-title":"Apoptosis"}],"container-title":["Blood Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328024000578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328024000578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T02:57:42Z","timestamp":1762657062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950328024000578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2950328024000578"],"URL":"https:\/\/doi.org\/10.1016\/j.bneo.2024.100057","relation":{},"ISSN":["2950-3280"],"issn-type":[{"value":"2950-3280","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid attenuates the efficacy of methotrexate against acute lymphoblastic leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Blood Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bneo.2024.100057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100057"}}